Managing Mild to Moderate Pediatric Atopic Dermatitis: Pathogenesis and Therapies for Improved Outcomes - A CE-Certified, Online Challenge

A fast, fun and effective way to improve the way you treat and manage pediatric atopic dermatitis. You choose how, where and when to participate via web or on your mobile device.
ARE YOU UP FOR THE CHALLENGE? ENROLL TODAY! https://www.surveymonkey.com/r/PediatricAD

This continuing education activity is administered by the National Association of Pediatric Nurse Practitioners (NAPNAP) as an Agency providing continuing education credit. Individuals who complete this program and will be awarded 1.5 NAPNAP contact hours, of which 0.75 is pharmacology content.

IMPORTANT: This continuing education activity is FREE to all participants.  

Participants are forbidden to reproduce, republish, redistribute, or resell this course in any other form. For copyright-related questions, please email your question to: ce@napnap.org
 

Target Audience

Pediatric-focused advanced practice registered nurses (APRNs)

Learning Objectives

Summarize the role of skin barrier dysfunction and inflammatory responses in atopic dermatitis pathogenesis
Recognize the symptoms of atopic dermatitis and how they differ in presentation in infants, children, and adolescents 
Evaluate the benefits and limitations of current therapies for mild to moderate atopic dermatitis
Assess the efficacy and safety of emerging therapies and their potential role in treating atopic dermatitis
 

Course summary
Available credit: 
  • 1.50 Contact hours
Course opens: 
11/01/2016
Course expires: 
12/30/2017
Cost:
$0.00

According to the disclosure policy of NAPNAP, all faculty, planning committee members, editors, managers, and other individuals who are in a position to control content are required to disclose any relevant relationships with any commercial interests related to this activity. The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation. All educational materials are reviewed for fair balance, scientific objectivity, and levels of evidence. Disclosures are as follows:
 

Activity Chair: 
Judith A. J. O’Haver, PhD, RN, CPNP-PC
Pediatric Nurse Practitioner
Nurse Researcher
Department of Dermatology
Phoenix Children’s Hospital
Phoenix, AZ

Disclosure Statements:

Judith A. J. O’Haver, PhD, RN, CPNP-PC - Research Support - Sub-investigator (institution): Anacor Pharmaceuticals, Inc

National Association of Pediatric Nurse Practitioners 
Heather Keesing, MSN, RN, APRN; Laura Nelsen; Daniela Weitzman: No relevant financial relationships with any commercial interests.

Spire Learning
Aisha Cobbs, PhD and Christine Kocienda: No relevant financial relationships with any commercial interests.

NAPNAP CE Chair
Lori Williams, DNP, RN, RNC-NIC, CCRN, NNP-BC: No relevant financial relationships with any commercial interests.
 

Available Credit

  • 1.50 Contact hours

Price

Cost:
$0.00
Please login or register to take this course.